LTRN
Lantern Pharma Inc
1.20$
+0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.6% | -9.0% | -10.4% | -14.9% | -15.6% | -17.5% | -17.4% | -21.8% | -19.0% | -34.5% | +19.1% | |
| – | -8.6% | -8.9% | -10.6% | -15.2% | -15.6% | -17.5% | -17.4% | -21.7% | -19.7% | -34.7% | +19.9% | |
| – | -14.2% | -16.3% | -29.3% | -37.6% | -7.3% | -15.1% | -5.0% | +38.4% | -47.3% | +11.2% | +35.4% | |
| – | -8.1% | -7.1% | -13.3% | -15.7% | -14.4% | -17.9% | -19.4% | -22.3% | -18.1% | -37.5% | +16.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +16.1% | +44.9% | +17.3% | -20.6% | +18.6% | -1.5% | +13.4% | -17.5% | +11.4% | -16.1% | +212.9% | |
| – | +18.9% | +47.6% | +16.4% | -21.7% | +20.3% | -1.0% | +13.9% | -17.3% | +11.4% | -16.1% | +14.4% | |
| – | +3.0% | +2.9% | -7.9% | +20.3% | -3.3% | -15.4% | -18.6% | -28.6% | -16.4% | -24.8% | -32.8% | |
| – | -54.8% | +71.1% | +175.2% | -23.3% | +21.6% | -0.4% | +15.2% | -17.0% | – | – | – | |
| – | -9.9% | -12.6% | -13.5% | -14.0% | -20.3% | -20.8% | -25.4% | -23.4% | -31.8% | -47.3% | -193.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.5% | -0.5% | +0.1% | +0.0% | +0.2% | +0.0% | +0.0% | +0.5% | +0.6% | +3.3% | +10.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.